It has been 20 years in the making, but a new regulatory scheme is quickly moving into force. This emerging regime may impact the development of, and intellectual property rights surrounding, an array of products, including pharmaceuticals, biotech products, agricultural products, nutritionals, supplements, cosmetics, perfumes and fragrances and industrial enzymes.

Please click here to view the full text of this article.

Originally published on Law360, New York (October 28, 2013)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.